Related Experiment Video
Updated: Jun 5, 2026

Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy
R Gardlik1, M Behuliak, R Palffy
1GI Cancer Laboratory, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. romangardlik@gmail.com
Abstract:
Several bacterial species have inherent ability to colonize solid tumors in vivo. However, their natural anti-tumor activity can be enhanced by genetic engineering that enables these bacteria express or transfer therapeutic molecules into target cells. In this review, we summarize latest research on cancer therapy using genetically modified bacteria with particular emphasis on blocking tumor angiogenesis. Despite recent progress, only a few recent studies on bacterial tumor therapy have focused on anti-angiogenesis. Bacteria-mediated anti-angiogenesis therapy for cancer, however, is an attractive approach given that solid tumors are often characterized by increased vascularization. Here, we discuss four different approaches for using modified bacteria as anti-cancer therapeutics--bactofection, DNA vaccination, alternative gene therapy and transkingdom RNA interference--with a specific focus on angiogenesis suppression. Critical areas and future directions for this field are also outlined.
Insights
Genetically engineered bacteria can fight cancer by targeting tumor blood vessel formation (angiogenesis). This review explores bacterial therapies, focusing on novel methods to suppress tumor growth and vascularization.
Area of Science:
- Oncology
- Microbiology
- Genetic Engineering
Background:
- Bacteria naturally colonize solid tumors.
- Genetic engineering enhances bacterial anti-tumor activity by delivering therapeutic molecules.
- Tumor angiogenesis is a critical target for cancer therapy.
Purpose of the Study:
- To review recent advancements in cancer therapy using genetically modified bacteria.
- To emphasize the application of these bacteria in blocking tumor angiogenesis.
- To outline future directions in bacteria-mediated anti-angiogenesis therapy.
Main Methods:
- Review of current research on genetically modified bacteria for cancer treatment.
- Focus on four therapeutic approaches: bactofection, DNA vaccination, alternative gene therapy, and transkingdom RNA interference.
- Analysis of methods specifically targeting angiogenesis suppression.
Main Results:
- Genetically modified bacteria offer a promising strategy for cancer therapy.
- Several approaches exist for engineering bacteria to express therapeutic molecules.
- Targeting tumor angiogenesis with bacteria is an attractive, yet under-explored, therapeutic avenue.
Conclusions:
- Bacteria-mediated anti-angiogenesis therapy presents a novel strategy for solid tumors.
- Further research is needed to fully exploit the potential of engineered bacteria in suppressing tumor vascularization.
- Future directions include refining existing methods and exploring new applications for bacteria in cancer treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Gene Therapy
Gene Therapy

